RK
Ravi Kulandasamy
About Ravi Kulandasamy
Data last updated:
Ravi Kulandasamy is a Director at Nuray Chemicals Private Limited (since 2020). The company operates in Pharma. Nuray Chemicals Private Limited reported revenue of ₹122 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuray Chemicals Private Limited U24110TN2012PTC086320 | Director | 04 Mar 2020 | 2012 | ₹122 Cr (FY 2025) | Active |
Board colleagues of Ravi Kulandasamy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ayyavu Rajavel | 02751833 | Nuray Chemicals Private Limited | Alternate Director |
| Jaganathan Jayaseelan | 01688806 | Nuray Chemicals Private Limited | Director |
| Shanmugam Muthusamy | 02684873 | Nuray Chemicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kulandasamy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kulandasamy
Ravi Kulandasamy currently holds 1 directorship: Nuray Chemicals Private Limited (Director, since 04 Mar 2020, revenue ₹122 Cr (FY 2025)).
Ravi Kulandasamy was first appointed on 04 Mar 2020 as Director at Nuray Chemicals Private Limited.
The current boards of Ravi Kulandasamy's companies include Ayyavu Rajavel (Nuray Chemicals Private Limited), Jaganathan Jayaseelan (Nuray Chemicals Private Limited), Shanmugam Muthusamy (Nuray Chemicals Private Limited).